Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Vonafexor by Enyo Pharma for Chronic Kidney Disease (Chronic Renal Failure): Likelihood of Approval
Vonafexor is under clinical development by Enyo Pharma and currently in Phase II for Chronic Kidney Disease (Chronic Renal Failure)....
Data Insights
Vonafexor by Enyo Pharma for Alport Syndrome: Likelihood of Approval
Vonafexor is under clinical development by Enyo Pharma and currently in Phase II for Alport Syndrome. According to GlobalData, Phase...